Medical News

RSS

FDA grants Advaxis pre-IND meeting for Advaxis-PSA immunotherapy for prostate cancer

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on August 10, 2011 to discuss the CMC, pharmacology, toxicology, and clinical plans for Advaxis PSA, its construct to fight prostate cancer.

1 Jul 2011

State roundup: Calif. braces for budget cuts; Mass. weighs premium freeze

Poor people will receive less medical care and welfare, disabled people will see fewer services, state parks will close and public university students will pay more in California under the budget that takes effect Friday. But also Friday, the state sales tax will decrease from 8.25 percent to 7.25 percent and vehicle licensing fees will drop by almost half. Combined with the taxes that expired in January, an average California family will pocket about $1,000 this year.

1 Jul 2011

Tranexamic acid effective for patients with head injury

New research has suggested that tranexamic acid has the potential to prevent people dying from head injuries.

1 Jul 2011

Roche introduces new real-time PCR system

With "Size: Reduced. Fun: Amplified.", Roche Applied Science launched its new real-time PCR system on June 27th, 2011. The small, silent, sleek LightCycler Nano Instrument supports state-of-the-art technology for fast PCR protocols featuring leading edge thermal resolution and reproducibility.

1 Jul 2011

Study: Heart transplant patients more likely to get serious skin cancers

A new study published in the American Journal of Transplantation reveals that there is a significant risk of serious skin cancers, including cutaneous squamous cell carcinoma and melanoma, in heart transplant patients.

1 Jul 2011

Positive results from Nexavar Phase 2b trial on breast cancer presented at ASCO

Accelerated Community Oncology Research Network, Inc., reported positive results of a large double-blind, randomized Phase 2b trial in patients with breast cancer at the American Society of Clinical Oncology (ASCO) 47th annual meeting in Chicago, June 3-7.

1 Jul 2011

Viewpoints: Abortion law debates; Medicare cost examinations; state reform building blocks

The Susan B. Anthony List's Pro-Life Leadership Pledge has garnered praise from a number of Republican presidential candidates, including Rick Santorum, Michele Bachmann, Newt Gingrich, Ron Paul and Tim Pawlenty, each of whom has signed the pledge. It has also faced some misinformed criticism, however, not only from the media but from other presidential candidates who refuse to sign on to the pledge's four basic principles.

30 Jun 2011

Positive topline results from Alkermes ALKS 9070 phase 1b study for schizophrenia

Alkermes, Inc. today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia.

30 Jun 2011

Some generic anti-epilepsy drugs may not be effective

Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests.

30 Jun 2011

Study confirms benefits of low-dose spiral CT scans for lung cancer detection

The New England Journal of Medicine's (NEJM) headline today read, "Reduced Lung Cancer Mortality with Low-Dose Computed Tomographic CT Screening," ending a long controversy over the use of an existing but underutilized early detection tool for those at risk for Lung Cancer. Preliminary results of the National Lung Screening Trial (NLST) were first released on November 4, 2010 and confirmed today.

30 Jun 2011

Researchers predict human's desired movements using brain signals

Bringing the real world into the brain scanner, researchers at The University of Western Ontario from The Centre for Brain and Mind (http://www.uwo.ca/its/brain/) can now determine the action a person was planning, mere moments before that action is actually executed.

30 Jun 2011

Auxilium reports three year data from XIAFLEX CORDLESS study in Dupuytren's contracture

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced three year recurrence data from the Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study (CORDLESS) for XIAFLEX® (collagenase clostridium histolyticum) in the treatment of adult Dupuytren's contracture patients with a palpable cord.

30 Jun 2011

CLC bio to provide free licenses for CLC Main Workbench to academic organizations in Japan

Today CLC bio Japan announced that they're expanding their Japanese outreach program in collaboration with RIKEN Omics Science Center to deliver free licenses for CLC Main Workbench to all academic organizations in the Tohoku earthquake and tsunami disaster area.

30 Jun 2011

First Edition: June 30, 2011

Today's headlines include reports about yesterday's decision from the 6th Circuit Court of Appeals upholding the health law.

30 Jun 2011

Chiropractors report high number of back-related injuries during summer moving period

Each year, chiropractors notice a recrudescence of patients that come for a consultation during the summer moving period. Not surprising when we know that many people, eager and tired, hasten to get everything done rapidly without worrying about their muscles and their back. That explains why herniated discs, lumbar pain and muscle soreness are so common during this time of year. How can we avoid this?

30 Jun 2011

Premature ejaculation treatment market to reach over $1.3 billion by 2017

In 2010 the premature ejaculation treatment market was estimated to be worth $684 million, according to a new research report available on companiesandmarkets.com.

30 Jun 2011

PENNSAID Viscous Solution Phase 2 clinical trial for osteoarthritis pain meets primary endpoint

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced receipt from Mallinckrodt Inc., a Covidien company (Covidien), of top-line results from a Phase 2 study conducted by Covidien, of twice-daily administration of PENNSAID Viscous Solution (topical diclofenac sodium viscous solution) 2% w/w, previously referred to as PENNSAID Gel.

30 Jun 2011

KCI receives reimbursement status for V.A.C.Via Negative Pressure Wound Therapy System

Kinetic Concepts, Inc. today announced that its groundbreaking V.A.C.Via Negative Pressure Wound Therapy System has been granted reimbursement status and will be listed on the U.K. Drug Tariff beginning August 1, 2011.

30 Jun 2011

Exposure to mobile phone derived electromagnetic fields can influence learning processes

High frequency non-ionizing radiation, emitted by mobile phones, is redundantly matter of discussions. The effects of high frequency electromagnetic fields derived from mobile phones have been discussed since the 1950's.

30 Jun 2011

Lotus Tissue Repair to develop DEB protein replacement therapy with $26 million Series A financing

Lotus Tissue Repair, Inc. today announced the closing of a $26 million Series A financing led by Third Rock Ventures. Proceeds of the financing will be used to advance the company's proprietary recombinant collagen type VII (rC7) technology as the first and only protein replacement therapy in development for the treatment of dystrophic epidermolysis bullosa (DEB), an orphan disease that causes devastating skin blisters, morbidity and early mortality.

30 Jun 2011

Medical News

FDA grants Advaxis pre-IND meeting for Advaxis-PSA immunotherapy for prostate cancer

State roundup: Calif. braces for budget cuts; Mass. weighs premium freeze

Tranexamic acid effective for patients with head injury

Roche introduces new real-time PCR system

Study: Heart transplant patients more likely to get serious skin cancers

Positive results from Nexavar Phase 2b trial on breast cancer presented at ASCO

Viewpoints: Abortion law debates; Medicare cost examinations; state reform building blocks

Positive topline results from Alkermes ALKS 9070 phase 1b study for schizophrenia

Some generic anti-epilepsy drugs may not be effective

Study confirms benefits of low-dose spiral CT scans for lung cancer detection

Researchers predict human's desired movements using brain signals

Auxilium reports three year data from XIAFLEX CORDLESS study in Dupuytren's contracture

CLC bio to provide free licenses for CLC Main Workbench to academic organizations in Japan

First Edition: June 30, 2011

Chiropractors report high number of back-related injuries during summer moving period

Premature ejaculation treatment market to reach over $1.3 billion by 2017

PENNSAID Viscous Solution Phase 2 clinical trial for osteoarthritis pain meets primary endpoint

KCI receives reimbursement status for V.A.C.Via Negative Pressure Wound Therapy System

Exposure to mobile phone derived electromagnetic fields can influence learning processes

Lotus Tissue Repair to develop DEB protein replacement therapy with $26 million Series A financing

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News